MorphoSys AG ADR Price Prediction

As of today the value of rsi of MorphoSys' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of MorphoSys' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of MorphoSys and does not consider all of the tangible or intangible factors available from MorphoSys' fundamental data. We analyze noise-free headlines and recent hype associated with MorphoSys AG ADR, which may create opportunities for some arbitrage if properly timed.
Using MorphoSys hype-based prediction, you can estimate the value of MorphoSys AG ADR from the perspective of MorphoSys response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MorphoSys to buy its stock at a price that has no basis in reality. In that case, they are not buying MorphoSys because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

MorphoSys after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-11.383.7918.96
Details

MorphoSys Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as MorphoSys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MorphoSys backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MorphoSys, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
4 Events / Month
18 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.00
0.00
0.00 
0.00  
Notes

MorphoSys Hype Timeline

On the 17th of December 2024 MorphoSys AG ADR is traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. MorphoSys is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on MorphoSys is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 1.5. MorphoSys AG ADR had not issued any dividends in recent years. Considering the 90-day investment horizon the next estimated press release will be in about 4 days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

MorphoSys Related Hype Analysis

Having access to credible news sources related to MorphoSys' direct competition is more important than ever and may enhance your ability to predict MorphoSys' future price movements. Getting to know how MorphoSys' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MorphoSys may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
IPSCCentury Therapeutics 0.01 7 per month 0.00 (0.06) 7.44 (7.41) 28.48 
EWTXEdgewise Therapeutics(2.19)10 per month 3.03  0.13  6.65 (5.54) 61.90 
CCCCC4 Therapeutics(0.11)6 per month 0.00 (0.11) 9.28 (7.99) 23.66 
MLYSMineralys Therapeutics, Common 0.95 7 per month 3.45  0.01  7.51 (5.79) 20.98 
CGEMCullinan Oncology LLC 0.14 9 per month 0.00 (0.18) 5.88 (7.24) 17.85 
ACLXArcellx(7.35)9 per month 3.21  0.03  6.28 (6.40) 16.07 
VTYXVentyx Biosciences 0.10 8 per month 3.91  0.01  9.35 (6.51) 31.94 
IMCRImmunocore Holdings 0.06 10 per month 0.00 (0.11) 2.97 (3.87) 10.46 
PCVXVaxcyte 1.08 11 per month 0.00 (0.20) 3.16 (4.09) 10.18 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.11  5.66 (2.91) 37.64 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
PMVPPmv Pharmaceuticals 0.03 3 per month 2.08 (0) 4.35 (4.57) 13.98 
ELVNEnliven Therapeutics 0.03 7 per month 2.43  0  5.84 (4.40) 13.82 
IMRXImmuneering Corp 0.08 7 per month 6.15  0.01  13.45 (10.59) 60.06 
RLYBRallybio Corp(0.03)5 per month 0.00 (0.06) 5.41 (4.63) 16.10 
GBIOGeneration Bio Co 0.21 4 per month 0.00 (0.25) 6.36 (8.20) 21.16 
MRSNMersana Therapeutics 0.18 8 per month 5.83  0.01  9.24 (10.81) 33.72 
GLUEMonte Rosa Therapeutics 0.84 9 per month 4.34  0.06  8.40 (8.46) 103.72 
REPLReplimune Group(0.70)8 per month 3.36  0.04  8.25 (5.60) 46.30 
NVCTNuvectis Pharma(0.27)10 per month 0.00 (0.02) 9.69 (10.50) 75.91 
LYRALyra Therapeutics 0.01 4 per month 0.00 (0.07) 10.53 (10.00) 41.07 
KRONKronos Bio(0.03)9 per month 3.52  0.0006  5.75 (6.25) 17.56 
GOSSGossamer Bio 0.00 8 per month 2.75 (0.02) 6.06 (4.76) 25.97 

MorphoSys Additional Predictive Modules

Most predictive techniques to examine MorphoSys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MorphoSys using various technical indicators. When you analyze MorphoSys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About MorphoSys Predictive Indicators

The successful prediction of MorphoSys stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MorphoSys AG ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MorphoSys based on analysis of MorphoSys hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MorphoSys's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MorphoSys's related companies.

Story Coverage note for MorphoSys

The number of cover stories for MorphoSys depends on current market conditions and MorphoSys' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MorphoSys is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MorphoSys' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

MorphoSys Short Properties

MorphoSys' future price predictability will typically decrease when MorphoSys' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MorphoSys AG ADR often depends not only on the future outlook of the potential MorphoSys' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MorphoSys' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding137.3 M
Cash And Short Term Investments682.8 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in MorphoSys Stock

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments